6-123804231-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001300737.2(NKAIN2):c.-37A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001300737.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NKAIN2 | NM_001040214.3 | c.31A>G | p.Ile11Val | missense_variant | 1/7 | ENST00000368417.6 | NP_001035304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NKAIN2 | ENST00000368417.6 | c.31A>G | p.Ile11Val | missense_variant | 1/7 | 5 | NM_001040214.3 | ENSP00000357402.1 | ||
NKAIN2 | ENST00000368416.5 | c.31A>G | p.Ile11Val | missense_variant | 1/4 | 1 | ENSP00000357401.1 | |||
NKAIN2 | ENST00000476571.1 | n.91A>G | non_coding_transcript_exon_variant | 1/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248982Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134836
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461758Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727176
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2024 | The c.31A>G (p.I11V) alteration is located in exon 1 (coding exon 1) of the NKAIN2 gene. This alteration results from a A to G substitution at nucleotide position 31, causing the isoleucine (I) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at